Micafungin alone and in combination therapy with deferasirox against Pythium insidiosum

R A Zanette1, F P K Jesus2, M B Pilotto3

  • 1Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Campus UFSM, Prédio 20, Sala 4139, 97105-900, Santa Maria, RS, Brazil.

Insights

Micafungin alone is ineffective against Pythium insidiosum. Combining micafungin with deferasirox showed synergy in vitro but led to lung dissemination in vivo, suggesting potential harm.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Pythium insidiosum is a fungus-like organism causing severe infections.
  • Antifungal treatments often have limited efficacy.
  • Iron availability can influence fungal growth and virulence.

Purpose of the Study:

  • To evaluate the efficacy of micafungin, an antifungal drug, against Pythium insidiosum.
  • To investigate the potential synergistic effect of combining micafungin with deferasirox, an iron chelator.
  • To assess the in vitro and in vivo activity of this combination therapy.

Main Methods:

  • In vitro susceptibility testing of micafungin and deferasirox against Pythium insidiosum strains.
  • In vivo efficacy study using a rabbit infection model.
  • Evaluation of lesion size and disease dissemination in infected rabbits.

Main Results:

  • Micafungin alone demonstrated poor in vitro activity against Pythium insidiosum.
  • A synergistic interaction between micafungin and deferasirox was observed in 88.2% of tested strains.
  • Combination therapy resulted in smaller lesions but promoted lung dissemination in vivo.

Conclusions:

  • Micafungin monotherapy is ineffective for treating Pythium insidiosum infections.
  • The combination of micafungin and deferasirox may have adverse effects, promoting disease spread.
  • Further research is needed to understand the complex interactions and host responses to this combination therapy.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
104
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
90
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
769
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
8.0K
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.2K